May 15 |
BioCardia Inc (BCDA) Q1 2024 Earnings Call Transcript Highlights: Strategic Progress Amid ...
|
May 15 |
BioCardia, Inc. (BCDA) Q1 2024 Earnings Call Transcript
|
May 14 |
BioCardia GAAP EPS of -$0.09, revenue of $0.05M
|
May 14 |
BioCardia Reports First Quarter 2024 Business Highlights and Financial Results
|
May 14 |
Most Shareholders Will Probably Find That The Compensation For BioCardia, Inc.'s (NASDAQ:BCDA) CEO Is Reasonable
|
May 9 |
BioCardia to Host Q1 2024 Financial Results and Corporate Update Conference Call on May 14, 2024
|
May 1 |
BioCardia’s CardiAMP Cell Therapy Chronic Myocardial Ischemia Trial Results Show Patient Benefits in Important Outcomes
|
Apr 25 |
BioCardia Completes Enrollment of CardiAMP Cell Therapy for the Treatment of Chronic Myocardial Ischemia Trial Open Label Roll-In Cohort
|
Apr 2 |
Insiders Are Buying These 11 Penny Stocks
|
Apr 1 |
BioCardia, Inc. (NASDAQ:BCDA) Q4 2023 Earnings Call Transcript
|